Locoregional therapy for cholangiocarcinoma

Current Opinion in Gastroenterology

Volumn 29, Issue 3, 2013, Pages 324-328

  Kuhlmann, Jan B ^a   Blum, Hubert E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

bile tract cancer; cholangiocarcinoma; radiofrequency ablation; selective intrahepatic radiotherapy; transcatheter arterial chemoembolization

Indexed keywords

CISPLATIN; GEMCITABINE; MITOMYCIN; OXALIPLATIN;

BILE DUCT CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; DISEASE SEVERITY; DRUG ELUTING STENT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEREOTACTIC BODY RADIATION THERAPY;

ANTINEOPLASTIC AGENTS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CATHETER ABLATION; CHOLANGIOCARCINOMA; DELAYED-ACTION PREPARATIONS; EMBOLIZATION, THERAPEUTIC; HUMANS;

EID: 84876296171     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32835d9dea     Document Type: Review

References (16)

1. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33:1353-1357.
2. Tan JC, Coburn NG, Baxter NN, et al. Surgical management of intrahepatic cholangiocarcinoma-a population-based study. Ann Surg Oncol 2008; 15:600-608.
3. Cunningham SC, Choti MA, Bellavance EC, Pawlik TM. Palliation of hepatic tumors. Surg Oncol 2007; 16:277-291.
4. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362:1273-1281.
5. Kim JH, Won HJ, Shin YM, et al. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol 2011; 196:W205-W209.
6. Xu HX, Wang Y, Lu MD, Liu LN. Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma. Br J Radiol 2012; 85:1078-1084.
7. Kiefer MV, Albert M, McNally M, et al. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. Cancer 2011; 117:1498-1505.
8. Vogl TJ, Naguib NN, Nour-Eldin NE, et al. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success. Int J Cancer 2012; 131:733-740.
9. Park SY, Kim JH, Yoon HJ, et al. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. Clin Radiol 2011; 66:322-328.
10. Shen WF, Zhong W, Liu Q, et al. Adjuvant transcatheter arterial chemoem-bolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study. World J Surg 2011; 35:2083-2091.
11. Kuhlmann JB, Euringer W, Spangenberg HC, et al. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy. Eur J Gastroenterol Hepatol 2012; 24:437-443.
12. Barney BM, Olivier KR, Miller RC, Haddock MG. Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma. Radiat Oncol 2012; 7:67.
13. Kopek N, Holt MI, Hansen AT, Hoyer M. Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 2010; 94: 47-52.
14. Polistina FA, Guglielmi R, Baiocchi C, et al. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, nonmeta-static, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiother Oncol 2011; 99:120-123.
15. Hoffmann RT, Paprottka PM, Schon A, et al. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovasc Intervent Radiol 2012; 35:105-116.
16. Vente MA, Wondergem M, van der Tweel I, et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured metaanalysis. Eur Radiol 2009; 19:951-959.